QQQ   357.80 (-0.03%)
AAPL   174.64 (-0.09%)
MSFT   316.60 (-0.13%)
META   297.81 (-0.42%)
GOOGL   129.85 (-0.31%)
AMZN   130.57 (+1.12%)
TSLA   241.62 (-1.33%)
NVDA   422.74 (+1.60%)
NIO   8.26 (-3.17%)
BABA   86.35 (-2.21%)
AMD   96.33 (+0.14%)
T   14.96 (-1.06%)
F   12.40 (-0.24%)
MU   68.74 (-0.20%)
CGC   0.90 (+6.68%)
GE   111.56 (+0.28%)
DIS   81.56 (+0.38%)
AMC   7.64 (+0.26%)
PFE   32.50 (-0.58%)
PYPL   58.37 (+0.85%)
NFLX   383.62 (+1.00%)
QQQ   357.80 (-0.03%)
AAPL   174.64 (-0.09%)
MSFT   316.60 (-0.13%)
META   297.81 (-0.42%)
GOOGL   129.85 (-0.31%)
AMZN   130.57 (+1.12%)
TSLA   241.62 (-1.33%)
NVDA   422.74 (+1.60%)
NIO   8.26 (-3.17%)
BABA   86.35 (-2.21%)
AMD   96.33 (+0.14%)
T   14.96 (-1.06%)
F   12.40 (-0.24%)
MU   68.74 (-0.20%)
CGC   0.90 (+6.68%)
GE   111.56 (+0.28%)
DIS   81.56 (+0.38%)
AMC   7.64 (+0.26%)
PFE   32.50 (-0.58%)
PYPL   58.37 (+0.85%)
NFLX   383.62 (+1.00%)
QQQ   357.80 (-0.03%)
AAPL   174.64 (-0.09%)
MSFT   316.60 (-0.13%)
META   297.81 (-0.42%)
GOOGL   129.85 (-0.31%)
AMZN   130.57 (+1.12%)
TSLA   241.62 (-1.33%)
NVDA   422.74 (+1.60%)
NIO   8.26 (-3.17%)
BABA   86.35 (-2.21%)
AMD   96.33 (+0.14%)
T   14.96 (-1.06%)
F   12.40 (-0.24%)
MU   68.74 (-0.20%)
CGC   0.90 (+6.68%)
GE   111.56 (+0.28%)
DIS   81.56 (+0.38%)
AMC   7.64 (+0.26%)
PFE   32.50 (-0.58%)
PYPL   58.37 (+0.85%)
NFLX   383.62 (+1.00%)
QQQ   357.80 (-0.03%)
AAPL   174.64 (-0.09%)
MSFT   316.60 (-0.13%)
META   297.81 (-0.42%)
GOOGL   129.85 (-0.31%)
AMZN   130.57 (+1.12%)
TSLA   241.62 (-1.33%)
NVDA   422.74 (+1.60%)
NIO   8.26 (-3.17%)
BABA   86.35 (-2.21%)
AMD   96.33 (+0.14%)
T   14.96 (-1.06%)
F   12.40 (-0.24%)
MU   68.74 (-0.20%)
CGC   0.90 (+6.68%)
GE   111.56 (+0.28%)
DIS   81.56 (+0.38%)
AMC   7.64 (+0.26%)
PFE   32.50 (-0.58%)
PYPL   58.37 (+0.85%)
NFLX   383.62 (+1.00%)
OTCMKTS:CAPS

Capstone Therapeutics (CAPS) Stock Forecast, Price & News

$7.50
0.00 (0.00%)
(As of 09/22/2023 ET)
Compare
Today's Range
$7.50
$7.50
50-Day Range
$7.50
$7.50
52-Week Range
$5.00
$20.00
Volume
2 shs
Average Volume
150 shs
Market Capitalization
$600,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CAPS stock logo

About Capstone Therapeutics (OTCMKTS:CAPS) Stock

Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.

CAPS Price History

CAPS Stock News Headlines

Capstone Holding Corp. Announces CFO Change
Would Buffett Approve of This Growth Strategy?
Warren Buffett's approach has been to find and invest in undervalued businesses with strong potential for growth. Taking this approach to heart and applying it to a Trillion Dollar industry has proved itself in a big way...achieving an incredible 400+% growth during a down market.
An Unusual Way to Invest in Gold
Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.
Capstone Therapeutics Corp
Hormel Foods announces free downtown concert
Max Q: Grounded
Stocks Build on Gains
See More Headlines
Receive CAPS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Capstone Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CAPS Company Calendar

Last Earnings
8/13/2018
Today
9/25/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CAPS
Employees
2
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
45,000
Market Cap
$600,000.00
Optionable
Not Optionable
Beta
131.81
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. Michael M. Toporek (Age 57)
    CEO, Pres & Chairman
  • Edward Schultz
    VP,CFO & Treasurer
  • Mr. Matthew E. Lipman (Age 44)
    VP, Sec. & Director













CAPS Stock - Frequently Asked Questions

How have CAPS shares performed in 2023?

Capstone Therapeutics' stock was trading at $37.00 at the beginning of 2023. Since then, CAPS shares have decreased by 79.7% and is now trading at $7.50.
View the best growth stocks for 2023 here
.

How were Capstone Therapeutics' earnings last quarter?

Capstone Therapeutics Corp. (OTCMKTS:CAPS) posted its quarterly earnings data on Monday, August, 13th. The biotechnology company reported $0.02 earnings per share for the quarter. The biotechnology company had revenue of $2 million for the quarter.

What other stocks do shareholders of Capstone Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Capstone Therapeutics investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cumberland Pharmaceuticals (CPIX), Entasis Therapeutics (ETTX), Evelo Biosciences (EVLO), Kaleido Biosciences (KLDO).

What is Capstone Therapeutics' stock symbol?

Capstone Therapeutics trades on the OTCMKTS under the ticker symbol "CAPS."

How do I buy shares of Capstone Therapeutics?

Shares of CAPS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Capstone Therapeutics' stock price today?

One share of CAPS stock can currently be purchased for approximately $7.50.

How much money does Capstone Therapeutics make?

Capstone Therapeutics (OTCMKTS:CAPS) has a market capitalization of $600,000.00.

How can I contact Capstone Therapeutics?

Capstone Therapeutics' mailing address is 1275 W. Washington Street Suite 104, Tempe AZ, 85281. The official website for the company is www.capstonethx.com. The biotechnology company can be reached via phone at (708) 371-0660, via email at investorinquiries@capstonethx.com, or via fax at 602-286-5300.

This page (OTCMKTS:CAPS) was last updated on 9/25/2023 by MarketBeat.com Staff

My Account -